论文部分内容阅读
头孢噻肟是一新的对革蓝氏阴性杆菌具有强大抗菌作用的广谱头孢菌素。本文报告国产头孢噻肟对临床分离的大肠杆菌、肺炎克氏杆菌、绿脓杆菌、肺炎球菌和金黄色葡萄球菌引起小鼠系统感染的保护治疗作用,并与头孢唑啉的保护治疗作用进行了对比。头孢噻肟对大肠杆菌和肺炎克氏杆菌引起的小鼠感染的保护治疗作用明显优于头孢唑啉,但对金黄色葡萄球菌引起的感染其保护作用不及头孢唑啉。头孢噻肟对绿杆菌和肺炎球菌引起的小鼠感染的治疗作用比头孢唑啉略强。这一实验结果与体外抗菌作用的研究结果一致。
Cefotaxime is a new broad-spectrum cephalosporin that has a strong antibacterial effect against gram-negative bacilli. This article reports the domestic Cefotaxime on the clinical isolation of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, pneumococcus and Staphylococcus aureus caused by the protective effect of systemic infection in mice and cefazolin protection and treatment were carried out Compared. Cefotaxime protects against infection caused by E. coli and Klebsiella pneumoniae in mice significantly better than that of cefazolin, but its protective effect is less than that of cefazolin in infections caused by Staphylococcus aureus. Cefotaxime has a slightly stronger therapeutic effect on cefazolin than mice infected with cocci and pneumococcus. This experimental result is consistent with the in vitro antibacterial effect.